FLT3LG and neoplasm: PARPi-FL uptake was also imaged in vivo in an orthotopic tongue tumor model of OSCC (FaDu cells) using the same parameters as for subcutaneous tumor imaging ex vivo (intravenous injection of 75 nmol PARPi-FL/animal, imaging 90 minutes post-injection).